DE602008004898D1 - Pharmazeutische Zusammensetzungen von Antikörpern von Viruserkrankungen - Google Patents
Pharmazeutische Zusammensetzungen von Antikörpern von ViruserkrankungenInfo
- Publication number
- DE602008004898D1 DE602008004898D1 DE602008004898T DE602008004898T DE602008004898D1 DE 602008004898 D1 DE602008004898 D1 DE 602008004898D1 DE 602008004898 T DE602008004898 T DE 602008004898T DE 602008004898 T DE602008004898 T DE 602008004898T DE 602008004898 D1 DE602008004898 D1 DE 602008004898D1
- Authority
- DE
- Germany
- Prior art keywords
- antibodies
- pharmaceutical compositions
- viral diseases
- interferon gamma
- peptide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08447031A EP2138513B1 (de) | 2008-06-27 | 2008-06-27 | Pharmazeutische Zusammensetzungen von Antikörpern von Viruserkrankungen |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602008004898D1 true DE602008004898D1 (de) | 2011-03-24 |
Family
ID=40032474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602008004898T Active DE602008004898D1 (de) | 2008-06-27 | 2008-06-27 | Pharmazeutische Zusammensetzungen von Antikörpern von Viruserkrankungen |
Country Status (8)
Country | Link |
---|---|
US (1) | US9409991B2 (de) |
EP (1) | EP2138513B1 (de) |
CN (1) | CN102216330B (de) |
AT (1) | ATE497978T1 (de) |
CA (1) | CA2729226C (de) |
DE (1) | DE602008004898D1 (de) |
ES (1) | ES2360334T3 (de) |
WO (1) | WO2009155670A2 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140242104A1 (en) * | 2011-10-12 | 2014-08-28 | Alpha-O Peptides Ag | Self-assembling peptide nanoparticles as vaccines against infection with norovirus |
US10574712B2 (en) | 2016-02-19 | 2020-02-25 | International Business Machines Corporation | Provisioning conference rooms |
WO2022031870A1 (en) * | 2020-08-05 | 2022-02-10 | Synthekine, Inc. | IL27Rα BINDING MOLECULES AND METHODS OF USE |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995005847A1 (en) * | 1993-08-20 | 1995-03-02 | University Of Medicine & Dentistry Of New Jersey | Accessory factor function for interferon gamma and its receptor |
RU2181297C2 (ru) | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
US7115264B2 (en) | 2001-11-05 | 2006-10-03 | Inhibitex | Monoclonal antibodies to the fibronectin binding protein and method of use in treating or preventing infections |
AU2003234443A1 (en) | 2002-05-01 | 2003-11-17 | Beth Israel Deaconess Medical Center | Use of anti-cd1 antibodies for the modulation of immune responses |
JP2004016021A (ja) * | 2002-06-12 | 2004-01-22 | Japan Science & Technology Corp | 抗体および阻害剤並びにそれを用いた形質転換方法および形質転換キット |
UA76638C2 (en) | 2002-08-02 | 2006-08-15 | Oleh Illich Epshtein | Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon |
WO2004050711A2 (en) | 2002-12-03 | 2004-06-17 | Sloan-Kettering Institute For Cancer Research | Gp120 specific antigens, conjugates thereof, methods for their preparation and uses thereof |
MXPA05007019A (es) * | 2002-12-30 | 2005-08-18 | Amgen Inc | Terapia de combinacion con factores co-estimuladores. |
US20050136103A1 (en) | 2003-09-17 | 2005-06-23 | Ben-Sasson Shmuel A. | Compositions capable of facilitating penetration across a biological barrier |
WO2006054129A1 (en) * | 2004-11-19 | 2006-05-26 | Institut Gustave Roussy | Improved treatment of cancer by double-stranded rna |
AR051836A1 (es) * | 2004-11-30 | 2007-02-14 | Centocor Inc | Antagonistas de receptor 3 simil toll metodos y usos |
UA92337C2 (uk) * | 2005-01-27 | 2010-10-25 | Новиммюн С.А. | ВИДІЛЕНЕ ПОВНІСТЮ ЛЮДСЬКЕ МОНОКЛОНАЛЬНЕ АНТИТІЛО ДО ГАММА-ІНТЕРФЕРОНУ (IFNγ), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ПОЛЕГШЕННЯ ІНТЕНСИВНОСТІ СИМПТОМУ АВТОІМУННОГО ЗАХВОРЮВАННЯ АБО ЗАПАЛЬНОГО РОЗЛАДУ |
ES2435775T3 (es) * | 2005-10-27 | 2013-12-23 | Janssen Biotech, Inc. | Moduladores de receptor tipo Toll 3, procedimientos y usos |
EP1975184A3 (de) * | 2007-03-26 | 2008-11-26 | Cell Signaling Technology, Inc. | Serin- oder Threonin-Phosphorylationsorte |
-
2008
- 2008-06-27 ES ES08447031T patent/ES2360334T3/es active Active
- 2008-06-27 EP EP08447031A patent/EP2138513B1/de not_active Not-in-force
- 2008-06-27 DE DE602008004898T patent/DE602008004898D1/de active Active
- 2008-06-27 AT AT08447031T patent/ATE497978T1/de not_active IP Right Cessation
-
2009
- 2009-06-26 CN CN200980127882.5A patent/CN102216330B/zh not_active Expired - Fee Related
- 2009-06-26 US US13/001,498 patent/US9409991B2/en active Active
- 2009-06-26 WO PCT/BE2009/000035 patent/WO2009155670A2/en active Application Filing
- 2009-06-26 CA CA2729226A patent/CA2729226C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP2138513B1 (de) | 2011-02-09 |
CA2729226C (en) | 2016-08-16 |
US9409991B2 (en) | 2016-08-09 |
WO2009155670A2 (en) | 2009-12-30 |
US20110177081A1 (en) | 2011-07-21 |
ES2360334T3 (es) | 2011-06-03 |
CN102216330A (zh) | 2011-10-12 |
WO2009155670A8 (en) | 2011-02-17 |
WO2009155670A3 (en) | 2010-04-01 |
EP2138513A1 (de) | 2009-12-30 |
CN102216330B (zh) | 2014-04-16 |
ATE497978T1 (de) | 2011-02-15 |
CA2729226A1 (en) | 2009-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1120137T1 (el) | Ενεσιμα σκευασματα βοτουλινικης τοξινης | |
CL2009002206A1 (es) | Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales. | |
CO6290682A2 (es) | Compuestos triciclicos fusionados inhibidores del virus de la hepatitis c. | |
BR122021002201A8 (pt) | Composto, composição, uso de um composto, e, método de tratamento de um distúrbio, condição ou doença | |
BR112012029975A2 (pt) | peptídeo como medicamento, em particular para o tratamento do câncer. | |
EA200802247A1 (ru) | Схема дозирования кладрибина для лечения рассеянного склероза | |
NI201100076A (es) | Péptidos antivirales terapéuticos. | |
MX2010001733A (es) | Compustos de imidazo[1,2-a]pirazina para tratamiento de infecciones virales tales como hepatitis. | |
CY1115253T1 (el) | Κρυσταλλικες μορφες ενος παραγωγου 2-θειαζολυλο-4-κινολινυλ-οξυ-ομαδας, ενος ισχυρου αναστολεα του ηcv | |
PE20120429A1 (es) | Proteinas de enlace de miostatina | |
BR112012011100A2 (pt) | compostos inibidores do vírus da hepatite, composição e uso dos mesmos | |
CL2009000305A1 (es) | Compuestos derivados de 2-aril-sustituido-1-benzofurano-3-carboxamida, inhibidores de la polimerasa ns5b; composicion farmaceutica; y su uso en el tratamiento de una enfermedad causada por el virus de la hepatitis c (hcv). | |
EA200970916A1 (ru) | Соединения 5,6-дигидро-1н-пиридин-2-она | |
BR112013020042A2 (pt) | inibidores de vírus da hepatite c | |
EP2186830A4 (de) | Polyethylenglykolmodifiziertes interferon alpha 2b und herstellungsverfahren und anwendungen davon | |
EP2078083A4 (de) | Neues hundeinfluenza-virus und imfpstoff hierfür | |
ES2530670T3 (es) | Anticuerpo anti-FGF23 y composición farmacéutica que comprende el mismo | |
UY30778A1 (es) | Compuestos de 5,6-dihidro-1h-piridin-2-ona | |
BRPI0511466A (pt) | agonistas peptìdicos do receptor de vasopressina | |
BR112013028679A2 (pt) | inibidores do vírus da hepatite c | |
CY1118399T1 (el) | Ενωσεις βενζοφουρανιου για την θεραπεια μολυνσεων ιου ηπατιτιδας c | |
PT2097068E (pt) | Formulações de conjugados de peg-interferão alfa | |
MA32841B1 (fr) | Composés de cycloundeca depsipeptides et leur utilisation comme médicament | |
CL2011003002A1 (es) | Anticuerpo monoclonal o un fragmento del mismo que se une a la proteina m2-1 del virus respiratorio sincicial (vrs) humano; secuencias nucleotidicas; composicion farmaceutica; metodo de diagnostico de infeccion producida por vrs; kit; y uso de dicho anticuerpo para preparar un medicamento. | |
EA200970831A1 (ru) | Композиции, содержащие конъюгаты пэг-интерферон-альфа и рафинозу в качестве криопротектора |